At-Home Light-Emitting Diode Devices Safe, Effective for Acne Treatment
By Lori Solomon HealthDay Reporter
THURSDAY, March 6, 2025 -- At-home light-emitting diode (LED) devices are effective for treating acne, according to a research letter published online March 5 in JAMA Dermatology.
Sherry Ershadi and John S. Barbieri, M.D., from Brigham and Women’s Hospital in Boston, conducted a systematic review and meta-analysis to synthesize the available data regarding the safety and efficacy of at-home LED devices in the treatment of mild-to-moderate acne.
Based on data from six studies (216 participants; age range, 12 to 50 years), the researchers found that compared with control, the LED devices resulted in greater percent change in inflammatory lesions (45.3 percent; I2 = 43.2 percent; five studies), noninflammatory lesions (47.7 percent; I2 = 83.22 percent; four studies), and the Investigator Global Assessment (45.7 percent; I2 = 54.85 percent; four studies). Red, blue, and combination wavelength devices were all effective. Benefit was typically seen after four to 12 weeks of use. There were no severe adverse reactions reported; however, a small number of patients did report mild dryness, erythema, or discomfort or pain during light therapy.
"At-home LED devices, particularly those that combine red and blue light, are efficacious for acne and can likely complement other over-the-counter and prescription treatments," the authors write.
Barbieri disclosed ties to Honeydew Care, Dexcel Pharma, and Sanofi Pasteur.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Adult Acne Linked to Higher Risk for Eating Disorders
WEDNESDAY, April 30, 2025 -- Adults with acne have a higher likelihood of having eating disorders, according to a letter to the editor published online April 16 in...
Benzoyl Peroxide Formulation Characteristics Explain Variation in Benzene Levels
WEDNESDAY, Feb. 19, 2025 -- Formulation characteristics can explain much of the observed variation in benzene levels of over-the-counter benzoyl peroxide-containing products...
FDA Approves Emrosi for Rosacea in Adults
TUESDAY, Nov. 12, 2024 -- The U.S. Food and Drug Administration has approved Emrosi (minocycline hydrochloride) for the treatment of inflammatory rosacea in adults. The...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.